Biomedical literature, made navigable
Discover articles through diseases, drugs, treatments, interventions, clinical instruments, institutions and funders extracted from the BMJ open corpus.
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsChoose an entity to see the articles in which it was identified.
….115 to 0.746; p 0.01) was associated with a lower incidence of osteoporosis.Conclusion The prevalence of osteoporosis in the SLE population…
…phy (PET). Its high affinity enables better lesion detection in prostate cancer compared to tracers like choline. This improved diagnostic perf…
…134 related pathways. The molecular docking results showed that curcumin has good binding ability to targets such as mitogen activated p…
…phylaxis (7%), fever of unknown origin (6%), and pneumonia (6%).Vancomycin was switched to linezolid in 40 treatments (58%), daptomycin in…
…rmacist-led follow-up and optimisation of antiemetic therapy in colorectal cancer patients receiving moderately emetogenic chemotherapy, quantify…
… from €18 to €14,567. By cancer type, the patients treated with pembrolizumab 2 mg/kg included: 16 with head and neck cancer, nine with cervi…
…eceived abiraterone, 31% apalutamide, 26% enzalutamide, and 11% docetaxel. Median PFS and OS were 32 and 50 months, respectively, in the …
…tient among 273 (0.37%) in ‘cohort A’ had an mycosis infection (C. albicans) requiring rehospitalisation at one year. Among the 295 patient…
…f care (26.3%). 31.5% of patients required a dose adjustment of binimetinib, and 21% discontinued treatment, with only one discontinuation …
…ndependent t-tests.Results ChatGPT-5 substantially outperformed ChatGPT-4o. The mean accuracy of correctly summarising ADRs was 77.9% (SD …
…nt regimen was tenofovir disoproxil fumarate/emtricitabine plus raltegravir (94.7%). Alternative regimens were prescribed in cases of renal…